iCAD ProFound AI

iCAD ProFound AI is a comprehensive artificial intelligence platform designed to revolutionize breast cancer screening and diagnosis. It comprises a suite of solutions including ProFound Detection for identifying potential cancers in mammograms, Density Assessment for evaluating breast density, and ProFound Risk for personalized cancer risk assessment. Developed by iCAD, a global leader in cancer detection technology, ProFound AI aims to improve the accuracy, efficiency, and effectiveness of breast cancer screening programs. The platform is FDA-cleared, CE marked, and available in over 50 countries, having analyzed an estimated 40 million mammograms worldwide in the past five years.

iCAD ProFound AI offers superior accuracy in detecting breast cancer earlier, provides objective breast density scoring, and calculates personalized short-term breast cancer risk. The suite includes modules for 2D and 3D mammography analysis, with clinically proven improvements in sensitivity, specificity, and reading time efficiency for radiologists.